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ABSTRACT
Metallic nanoparticles of gold functionalized with
oligonucleotides conventionally use a terminal thiol
modification and have been used in a wide range
of applications. Although readily available, the
oligonucleotide–nanoparticle conjugates prepared
in this way suffer from a lack of stability when
exposed to a variety of small molecules or elevated
temperatures. If silver is used in place of gold then
this lack of stability is even more pronounced. In this
study we report the synthesis of highly stabilized
oligonucleotide–nanoparticle conjugates using a
simple oligonucleotide modification. A modified
solid support was used to generate 30-thioctic acid
modified oligonucleotides by treatment with an N-
hydroxysuccimidyl ester of thioctic acid. Unusually,
both gold and silver nanoparticles have been
investigated in this study and show that these
disulphide-modified oligonucleotide probes offer
significant improvements in nanoparticle
stability when treated with dithiothreitol (DTT)
compared with monothiol analogues. This is a
significant advance in oligonucleotide–nanoparticle
conjugate stability and for the first time allows silver
nanoparticles to be prepared that are more stable
than standard gold-thiol functionalized nanoparti-
cles. This opens up the possibility of using silver
nanoparticles functionalized with oligonucleotides
as an alternative to gold.
INTRODUCTION
The area of molecular diagnostics is at the forefront of
modern bioanalytical research and a sector of growing
importance is the interface with materials science on the
nanoscale and the conjugation of metallic nanoparticles
with biomolecules (1–5). The ability to detect DNA
sequences in an highly selective manner for the rapid
detection of genetic mutations and disease states is of
ever growing interest and central to a number of new
approaches to disease management. Speciﬁc DNA
sequences can be detected by hybridization to comple-
mentary oligonucleotide probes conjugated with nano-
particle substrates in a number of diﬀerent ways (1). Gold
nanoparticles have been most widely used in this manner
with oligonucleotide adsorption typically achieved
through thiol modiﬁcation, following Brust’s observation
that alkylthiols stabilize gold colloidal solutions (6–8).
Bioanalytical probes based on those observations have
been shown to be capable of discriminating between fully
complementary and single base mismatched sequences (9).
This approach relies on the hybridization-induced
reversible aggregation of the nanoparticles resulting in
a distinctive red-shifting of the plasmon of the nano-
particles. The nanoparticles have unusually high extinc-
tion coeﬃcients in the visible region of the spectrum which
makes them easy to visualize colourimetrically, by eye or
instrumentation, when a change in the plasmon relating
to hybridization takes place. A particular disadvantage
of the thiol adsorption strategy to immobilize the oligo-
nucleotide probe on the gold is its lability under certain
conditions such as prolonged or cycled elevated
temperatures, high NaCl concentrations and treatment
with biological buﬀer additives e.g. dithiothreitol (DTT)
or mercaptoethanol (10). Upon thiol desorption,
irreversible aggregation occurs and the probe system
is rendered inactive. To minimize these undesirable
aggregation events, structurally complex multiple thiol
linker systems have been investigated but were only ever
reported as being used with gold nanoparticles (10,11).
Thioctic acid is an inexpensive, commercially available
and structurally simple disulphide species. Herein we
report its preliminary employment as a linker molecule for
oligonucleotide nanoparticle functionalization of greater
stability than standard thiol analogues. Thioctic acid has
received great attention in recent years in the area of gold
and silver nanoparticle functionalization for a variety of
applications (12–18), ranging from the immobilization of
tetrathiofulvalenes as cation sensors on gold electrodes
(12) and the investigation of metal ion chelation (13),
to the probing of nanoparticle surface adsorption by
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Indeed, it has also been used to immobilize molecules for
bioanalytical applications; carbohydrates for non-speciﬁc
protein interactions (15), antibodies (16) and transition
metal complexes for protein capture (17). From an
oligonucleotide perspective thioctic acid oligonucleotide
templates have been generated by attachment to gold
nanoparticles via mid-sequence amino-modiﬁed sites (18)
and via multiple-step post-synthetic modiﬁcation (19),
however, there was no data presented on the subsequent
improved properties of the oligonucleotide–nanoparticle
conjugates (18). Until now, the stability of thioctic
acid functionalized oligonucleotide–nanoparticle conju-
gates has not been reported and their ultimate applica-
tion to oligonucleotide sequence analysis has not been
realized.
INSTRUMENTATION
1H NMR and
13C NMR were recorded on a Bru ¨ ker DPX
400MHz spectrometer with the appropriate solvent peak
as reference. J values are quoted in Hertz. Mass spectro-
metry was carried out as a service by Swansea EPSRC
mass spectrometry centre. Preparative reversed phase
HPLC was carried out on a Dionex UVD170U detector
ﬁtted with a P680 pump through a Phenomenex Clarity
column. Desalting HPLC was carried out on a Biocad
Sprint HPLC using a HiTrap (5ml) size exclusion column.
Oligonucleotides were synthesized on an MerMade 6
Nucleic Acid Synthesiser, unless otherwise stated.
ZipTipC18 puriﬁcation pipette tips were purchased from
Millipore Corp. Oligonucleotide synthesis reagents were
purchased from Link Technologies.
MATERIALS AND METHODS
1-{[5-(1,2-dithiolan-3-yl)pantanoyl]oxy}-
2,5-pyrrolidinedione, 1
N-(3-Dimethylaminopropyl)-N0-ethylcarbodiimide hydro-
chloride (EDC.HCl) (1.840g, 9.6mmol, 1.2 eq) was
dissolved in DCM (anhydrous, 20ml), which, 1.7ml
diisopropylethylamine (DIPEA) (anhydrous, 9.6mmol,
1.2 eq) was added and stirred for 10min. To the solution
N-hydroxysuccinimide (1.290g, 11.2mmol, 1.4 eq) was
added and the reaction mixture stirred in an ice bath.
Thioctic acid (1.643g, 8.0mmol, 1.0 eq) was dissolved in
anhydrous DCM (10ml) and added to the reaction over
5min and stirred overnight. The reaction mixture was
washed with HCl (5% (v/v), 50ml 2) and water
(distilled, 50ml). The organic layer was dried over
Na2SO4. Solvents were concentrated in vacuo to yield
2.236g of ester 1, as a yellow, solid. The residue was
dry-loaded on Na2SO4 and the product puriﬁed by ﬂash
column chromatography giving the product in 83%
yield. dH(400MHz; DMSO) 1.4–1.7 (6H, m,C H 2 3),
1.84–1.93 (1H, m, CH), 2.38–2.46 (1H, m, CH), 2.68 (2H,
t, J 7.2, CH2), 2.81 (4H, s, succinimidyl CH2 2),
3.12–3.21 (2H, m, CH2), 3.56–3.65 (1H, m, CH).
dC(400MHz; DMSO) 24.415, 25.830, 28.026, 30.425,
34.217, 38.485, 56.011, 169.287, 170.612. M/Z 321.0937
([MþNH4
þ]C 12H17NO4S2 requires, 321.0937).
Synthesis of 30-disulphide-modified oligonucleotides
The NHS ester, 1, was added to the 30-end of oligonucleo-
tides (50- FAM CAT TGA AGC TTC (Pr1), 50- FAM
CAT TGA AGC TTC TTT TTT TTT T (Pr2), 50-FAM
CAT TGA AGC TTC AAA AAA AAA A (Pr3) and
50- ATC CTG AAT GCG AAA AAA AAA A (Pr4)) using
30-amino-modiﬁer C7 CPG solid supports (1mmol).
The Fmoc protecting group was removed from the
30-amino group by treatment with 20% (v/v) piperidine/
MeCN for 30min. The NHS ester, 1 (20mg in 1ml of
MeCN) was applied to the column overnight then washed
with MeCN (3 1ml) before being used as the solid
support for oligonucleotide synthesis. The oligonucleotide
sequence was prepared on a MerMade 6 Nucleic Acid
Synthesiser with the FAM introduced as a commercially
available terminal phosphoramidite. The oligonucleotides
were cleaved from the CPG supports by incubation in
1ml of conc. NH4OH for 3 days at room temperature.
The ammonium hydroxide was removed in vacuo (room
temperature) and re-dissolved in H2O (1ml, distilled) and
puriﬁed by reversed-phase HPLC on a Dionex UVD170U
detector ﬁtted with a P680 pump through a Phenomenex
Clarity column. Buﬀer A: TEAA (0.1M, pH 7), Buﬀer B:
CH3CN; T¼0, 95% TEAA: 5% MeCN, with a gradient
of 1% min
 1 B over 15min and held at 20% B for 5min
at a ﬂow rate of 1ml/min. After HPLC puriﬁcation the
fractions were collated and concentrated in vacuo (room
temperature) and redissolved in H2O (1ml, distilled),
they were then freeze-dried and redissolved in H2O (1ml,
distilled) and stored at 48C. HPLC analysis of 30-thioctic
acid, 50-FAM-modiﬁed oligonucleotides indicated mod-
iﬁcation had occurred. Conﬁrmation of this was achieved
by reference to MALDI mass spectrometry of a known
thioctic acid modiﬁed sequence, M/Z 3977.6 ([MALDI]
C15H28NO3S2-ATGCTCAACTCT requires, 3977.4).
Synthesis of 30-thiol-modified oligonucleotide probes
Sequences were prepared on a MerMade 6 Nucleic Acid
Synthesiser with commercially available 30-thiol-modiﬁed
universal support (propyl) and FAM introduced at the
50-end by a commercially available phosphoramidite.
The oligonucleotides were cleaved from the CPG supports
by incubation in 1ml of conc. NH4OH for 3 days at room
temperature. The ammonium hydroxide was removed
in vacuo (room temperature) and re-dissolved in H2O
(1ml, distilled) and puriﬁed by reversed-phase HPLC on
a Dionex UVD170U detector ﬁtted with a P680
pump through a Phenomenex Clarity column. Buﬀer A:
TEAA (0.1M, pH 7), Buﬀer B: CH3CN; T¼0, 95%
TEAA: 5% MeCN, with a gradient of 1% min
 1 B over
15min and held at 20% B for 5min at a ﬂow rate of
1ml/min. After HPLC puriﬁcation, the fractions were
collated and concentrated in vacuo (room temperature)
and redissolved in H2O (1ml, distilled), they were then
freeze-dried and then redissolved in H2O (1ml, distilled)
and stored at 48C.
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Thirteen nanometre gold nanoparticles were prepared via
citrate reduction of HAuCl4. Thirty seven nanometre
silver nanoparticles were prepared via citrate reduction of
AgNO3.
Disulphide-modified oligonucleotides. Desalted oligonu-
cleotide (5.71nmol) was added to Au (3ml, 17nM) or
Ag (3ml, 1.0nM) colloid in an autoclaved glass vial.
After 18h, phosphate (NaH2PO4/Na2HPO4) buﬀer
(60mM) was added to 10mM ﬁnal concentration. 2M
NaCl was then added at intervals, increasing the salt
concentration by 0.05M ncrements to a ﬁnal concentra-
tion of 0.3M. The oligonucleotide–gold conjugates were
stored at 48C.
Thiol-modified oligonucleotides. Desalted oligonucleotide
(5.71nmol) was added to Au (3ml 17nM) or Ag
(3ml, 1.0nM) colloid in an autoclaved glass vial. After
18h, phosphate (NaH2PO4/Na2HPO4) buﬀer (60mM)
was added to 10mM ﬁnal concentration. 2M NaCl was
then added at intervals, increasing the salt concentration
by 0.05M (ﬁnal concentration) increments to a ﬁnal
concentration of 0.3M. The oligonucleotide–gold con-
jugates were stored at 48C.
Pre-treated thiol-modified oligonucleotides. An aliquot
of 1ml of desalted oligonucleotide (10mM) in Na2HPO4
(pH 8.5) was shaken with DTT (0.1M) for 30min. DTT
was removed by size exclusion chromatography though
a Hi-Trap desalt column and 1ml of the oligonucleotide
collected directly onto 3ml of Au or Ag colloid.
RESULTS
Synthesis of thioctic-modified oligonucleotides
A number of options were considered for the attachment
of thioctic acid to oligonucleotides. Ultimately, the
synthesis of an active ester of the thioctic acid was
determined as being the most versatile approach to
functionalizing the termini of oligonucleotides. Primary
amine groups are readily added to the 30-o r5 0-termini
of oligonucleotides and will react with the active ester of
thioctic acid either on a solid support or in solution to
provide the disulphide functionalized oligonucleotide.
In addition the thioctic acid was shown to be stable to
the conditions used for oligonucleotide synthesis and
deprotection indicating its compatibility with routine
oligonucleotide synthesis. The N-hydroxysuccinimidyl
ester, 1, of thioctic acid was prepared in good yield by
the esteriﬁcation of the carboxylic acid with hydroxysuc-
cinimide using EDC (Scheme 1). This active ester was then
used in two diﬀerent approaches.
Modiﬁcation at the 30-terminus was achieved by using
an amino-modiﬁed solid support. Initially, the Fmoc
protecting group was removed using standard piperidine
deprotection to give the free amine on the CPG.
The active ester was added to the CPG in acetonitrile
and left overnight (Scheme 2). Following washing with
acetonitrile, the thioctic acid solid support was used with
standard phosphoramidite chemistry.
Three sequences were generated with the thioctic acid
modiﬁcation at the 30-terminus and a FAM label at the
50-terminus: 50- FAM CAT TGA AGC TTC (Probe 1),
50- FAM CAT TGA AGC TTC TTT TTT TTT T
(Probe 2) and 50-FAM CAT TGA AGC TTC AAA AAA
AAA A (Probe 3), respectively. The sequences chosen
were designed to assess whether the presence of spacer
bases (adenine or thymine) would aﬀect stability and/or
surface coverage of the Au or Ag conjugates. Preparing
both disulphide (DX) and thiol (TX) analogues allows
for comparison of surface coverage and assessment of
stability of the nanoparticle–oligonucleotide conjugates
(where X denotes the Probe sequence as indicated above).
In addition, thiol conjugates were prepared that omitted
the treatment of DTT prior to conjugation (TTX).
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Scheme 2. (i) 20% Piperidine/MeCN (v/v), 30min and (ii) 1, MeCN, overnight.
3670 Nucleic Acids Research, 2007, Vol. 35, No. 11This is usually carried out to ensure that the thiol-modiﬁed
oligonucleotide is in a mono-thiol form, rather than
disulphide, when applied to the nanoparticles.
Nanoparticle functionalization and stability studies
Gold nanoparticle stability. Immobilization of the
disulphide-modiﬁed oligonucleotide sequences, D1, D2
and D3 on citrate-reduced gold nanoparticles (20) was
carried out using standard protocols with incremental
elevation of NaCl concentration. In earlier investigations,
thioctic acid oligonucleotides were added to gold nano-
particles in water and after 18h phosphate buﬀer added
followed by aliquots of NaCl over 5 days to give a ﬁnal
salt concentration of 0.3M. If the salt concentration is
raised too rapidly then the nanoparticles can precipitate
if a thiolated oligonucleotide is used. The NaCl concen-
tration of the disulphide-modiﬁed sequences, while still
raised incrementally, was condensed to a considerably
shorter timescale of 2 days, whilst maintaining nanopar-
ticle stability on citrate-reduced gold and silver nano-
particles. The ﬁnal conditions of the conjugate materials
were 10mM phosphate, pH 7, 0.3M NaCl (0.3M PBS).
Thiol-modiﬁed oligonucleotides (1ml, 10mM) were
subjected, as standard, to treatment with DTT, 0.1M,
phosphate at pH 8.5 for 30min before desalting directly
onto the nanoparticles, generating probes T1, T2 and T3.
A set of oligonucleotide–nanoparticle conjugates were
also prepared without this DTT treatment prior to
addition of oligonucleotide, probes TT1, TT2 and TT3.
Both sets of thiol-modiﬁed oligonucleotides were treated
to a ‘softer’ salt-ageing process and were complete in
5 days.
Following literature precedent, the eﬀect of the thioctic
acid linker moiety on the stability of oligonucleotide–
nanoparticle conjugates, was assessed by treating the
conjugates with DTT (10mM ﬁnal concentration) at
408C (10,22). Typical UV–Vis spectra taken periodically
for both thiolated (T3at 1min intervals) and disulphide-
modiﬁed oligonucleotide (D1at 10min intervals) gold
conjugates are shown in Figure 1. Figure 1a shows the
rapid degradation of the conjugates typical of thiolated
oligonucleotides. Even from these ‘busy’ plots, the
enhancement in stability of the conjugates can be seen
when employing the disulphide modiﬁcation, as each entry
signiﬁes another 10min interval cf. 1min for the thiol plot.
Monitoring the disappearance of the plasmon band at
520nm and the appearance of one between 600 and
700nm indicates the progressive aggregation event when
gold nanoparticles are used. Absorption spectra were
taken at periodic intervals. Plotting absorbance at a
particular wavelength versus time for each experiment
clearly shows the stability of the system. This was carried
out for the D1–Au, D2–Au, D3–Au, TT1–Au, TT2–Au,
TT3–Au, T1–Au, T2–Au and T3–Au conjugates. Figure 2
shows the absorbance versus time at the ‘signiﬁcant’
675nm plasmon wavelength for each of these samples.
The DX results (Figure 2a) are plotted together to
highlight the eﬀect of spacer bases as are TX
(Figure 2b). Note that TTX–Au conjugates show the
same proﬁle as those in Figure 2b.
The half-life (time taken for absorbance at 675nm to
reach half the value for complete aggregation) was
calculated for each conjugate (Table 1) for ease of
comparison.
The disparate stabilities of the thiol and disulphide
systems are striking when comparing the half-lives of the
conjugate systems. All of the Au-monothiol systems have
reached the half-way point of complete aggregation in
1min or less. Compare this with the thioctic acid
disulphide system and the enhanced stability is clear
with half-lives of 140, 195 and 245min. It should be noted
(as shown in Figure 2a) that DTT-induced aggregation
event is not linear, a long period of sustained stability is
followed by a sharp increase in absorbance. With the
disulphide conjugates (Figures 2a), aggregation begins at
90min for D1 (no spacers) or 2h incubation for D2 and
D3 (polyT and polyA spacers, respectively) and is
considerable by 3h. This is an excellent enhancement
when compared with the monothiol results (Figure 2b)
which show complete aggregation in 55min. The emer-
gence of the 675nm peak is indicative of nanoparticle
aggregation, however, by 300min in the disulphide system
there is a loss of signal altogether; this feature can be
attributed to the aggregate species growing in size and
(a) (b)
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
300 400 500 600 700 800
Wavelength (nm)
300 400 500 600 700 800
Wavelength (nm)
A
b
s
o
r
b
a
n
c
e
−0.1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
A
b
s
o
r
b
a
n
c
e
Figure 1. UV–Vis spectra showing degradation upon treatment with 10mM DTT of (a) T3–Au conjugates at 1min intervals and (b) D1–Au
conjugates at 10min intervals. Arrows added to highlight the ‘movement’ of the spectra with time.
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a colourless mother liquor.
In similar studies where a steroidal disulphide was used
Mirkin and co-workers state that the structurally complex
steroidal disulphide system begins aggregation after 2h
(10). This, he argues, is due to a hydrophobic ‘screening’
eﬀect of the gold surface as well as the formation of
a chelate structure. Indeed the dihydrothioctic acid,
the reduced dithiol, form of thioctic acid is known to
bind through both sulphur atoms (22), and form stable
monolayers on gold surfaces, and this now appears to be
the driving factor in stability enhancement as similar
results have been obtained in this non-steroidal system.
It is worthy to note that Mirkin achieved further
enhancement of stability when employing a complex
trithiol head group (which maintained optical stability
for 10h) (10).
Comparison of thiol anddisulphide surface coverage
Whilst there is no doubt that the result of employing
disulphide attachment of oligonucleotides to nanoparticles
is enhanced stability of the ‘conjugate’ species cf. mono-
thiol, one cannot immediately make the argument that this
is due to the disulphide–gold interaction being greater
than the thiol–gold one. There are many factors which
inﬂuence the stability of oligonucleotide conjugates and
surface coverage plays an important role.
For this reason the surface coverage of each of the
conjugate systems was assessed (Table 2). This was carried
out by a method devised by Mirkin et al. (23) Triplicates
of the FAM-modiﬁed oligonucleotide conjugates were
treated with DTT (10mM) and left to completely
aggregate. After which they were centrifuged to ensure
that all nanoparticulate sediment was separated from
the supernatant. Aliquots of the supernatant were taken,
again in triplicate, and ﬂuorescence measured. These
ﬂuorescence values when correlated with a standard
calibration curve gave a concentration for FAM-labelled
oligonucleotide in solution. This FAM-oligonucleotide
concentration divided by the starting molar concentration
of nanoparticle gives a value of oligonucleotides per
nanoparticle and dividing by the surface area of the sphere
gives normalized surface coverage values which are easily
converted to pmol cm
 2.
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Figure 2. Monitoring the emergence of the plasmon at 675nm against time gives an indication of the durability of the oligonucleotide conjugates
when subject to the same conditions. Figures (a) and (b) show the plots of the DX–Au and TX–Au conjugates at 675nm, respectively. These results
are pronounced when the timescale over which they were acquired are considered.
Table 1. Half-lives for Au–oligonucleotide conjugates
Probe t1/2 (min)
D1–Au 140.0
D2–Au 245.0
S S
R
D3–Au 195.0
TT1–Au 0.5
TT2–Au 1.0
S
R
S
R
TT3–Au 0.5
T1–Au 0.75
T2–Au 1.0 
HS
R
T3–Au 1.0
Table 2. Surface coverage data for oligonucleotide–nanoparticle
conjugates
Probe
name
Surface coverage
(pmol cm
 2)
Standard
deviation
Probe
name
Surface coverage
(pmol cm
 2)
Standard
deviation
D1–Au 7.4 0.3 D1–Ag 21.1 1.3
D2–Au 59.9 6.7 D2–Ag 331 8.3
D3–Au 12.6 0.8 D3–Ag 105.7 0.9
TT1–Au 17.5 0.5 TT1–Ag 144.7 14.0
TT2–Au 12.0 0.3 TT2–Ag 38.1 6.5
TT3–Au 21.1 1.2 TT3–Ag 76.1 2.2
T1–Au 12.6 0.6 T1–Ag 31.2 1.5
T2–Au 21.1 1.2 T2–Ag 64.4 3.0
T3–Au 12.2 0.7 T3–Ag 123.1 15.1
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oligonucleotide surface coverage than both TT1 and T1
7.4 0.3 pmol cm
 2 cf. 17.5 0.5 pmol cm
 2 and
12.6 0.6 pmol cm
 2, respectively. This shows that with
no spacer bases the surface coverage by thioctic acid
modiﬁed oligonucleotide–Au nanoparticle conjugates is
less than that of the standard thiol conjugates. In turn,
the surface coverage of standard thiol conjugates is found
to be less than those that are not treated with DTT prior
to conjugation (when the oligonucleotides are added
directly to the nanoparticles without treating with DTT
and purifying with size exclusion chromatography). This
indicates that the conjugation process can be improved
when using alkyl-thiolated oligonucleotides as there is no
trade-oﬀ in conjugate stability or surface coverage as
a result of omitting reduction by DTT.
With the polyT spacer, D2, there is greater surface
coverage of the Au nanoparticle by the oligonucleotide,
59.9 6.7 pmol cm
 2 compared with 12.0 0.3
pmol cm
 2 and 21.1 1.2 pmol cm
 2 for the TT2 and
T2 samples. Therefore, it is diﬃcult to argue that the
enhanced stability was due to an increased surface
coverage since in the previous case, without spacers,
there is decreased surface coverage and the enhanced
conjugate stability is still observed.
Indeed, moving to the polyA spacer, D3, the surface
coverage is in line with the thiol systems at 12.6 0.8
pmol cm
 2 cf. 21.1 1.2 pmol cm
 2 and 12.2 0.7
pmol cm
 2 for TT3 and T3. Again, as this disulphide
conjugate has the same surface coverage as the standard
monothiol the enhanced stability cannot be attributed
to surface coverage eﬀects.
Whilst these surface coverage results are variable
depending upon whether spacer bases are present and
indeed which spacers are utilized, it can clearly be seen
that the enhanced stability of the conjugate systems
cannot be determined by surface coverage. If that was
the inﬂuencing factor we would expect to see discrepancies
in the stability between the disulphide examples in line
with surface coverage. That is, D1 would be the least
stable, D3 would be of intermediate stability and D2
would be the most stable. This is not observed as D3 and
D2 show very similar stability proﬁles, despite a reason-
ably large diﬀerence in surface coverage.
Silver nanoparticle–oligonucleotide conjugatestability
To demonstrate the versatility of the thioctic acid modiﬁed
oligonucleotides, silver nanoparticles were used in a
similar study. Silver nanoparticles are considerably less
stable than gold and as a consequence have been subject
to less success in DNA sensing primarily due to the lack
of robust surface chemistry. A limited number of studies
have been reported but use homo-oligonucleotides or
direct hybridization approaches (24–26). Figure 3 shows
the degradation of thioctic acid- and thiol-terminated
oligonucleotide sequences immobilized on 37nm citrate-
reduced silver nanoparticles. Figure 3 again shows the
progressive red-shift of absorbance as a result of aggrega-
tion. The thiol system taken at 1min intervals is clearly
less stable than the disulphide which was monitored at
10min intervals.
It should be noted that with oligonucleotide–Ag
conjugates rather than a new peak appearing at red-
shifted wavelength due to a change in plasmon on the
nanoparticle surface, the plasmon broadens and there is
a loss of absorbance at 407nm. For that reason it is less
informative to plot an ‘emergence’ proﬁle for the silver
conjugates and their stability was assessed by reference to
the 407nm peak. For ease of comparison the ‘half-lives’
of the conjugate systems were calculated, taken as the
time required for half the total absorbance change to
occur at 407nm, the results are shown in Table 3.
With both the thiol and disulphide–Ag conjugate
systems aggregation commences immediately upon treat-
ment with DTT (10mM). There is a marked diﬀerence
in the rate of aggregation, however, with all of the thiol
systems having a half-life of less than a minute, compared
with the disulphide examples which have 15–30min
half-lives. Whilst it is diﬃcult to compare gold and silver
conjugate systems, we can say that the overall ‘conjugate’
stability displayed by the silver–disulphide systems is more
stable (with respect to DTT-induced aggregation) than
the ‘standard’ thiol–gold system (see Figure 2).
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
300 400 500 600 700 800
A
b
s
o
r
b
a
n
c
e
A
b
s
o
r
b
a
n
c
e
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4 (b) (a)
Wavelength (nm)
300 400 500 600 700 800
Wavelength (nm)
Figure 3. UV–Vis spectra taken for (a) D1–Ag conjugates at 10min intervals and (b) T3–Ag conjugates at 1min intervals again clearly shows
enhanced stability on the conjugates when thioctic acid tethering to the nanoparticles is employed.
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of the conjugates as a high surface coverage could explain
enhanced stability. As with the gold conjugates the
surface coverage data is variable depending upon whether
there are spacer bases and what those spacer bases are.
For example, the surface coverage of oligonucleotide on
Ag nanoparticles for D1–Ag conjugates was found to be
21.1 1.3 pmol cm
 2, compared with TT1–Ag which
have a greater surface coverage, 144.7 14 pmol cm
 2.
Even T1–Ag has a greater surface coverage than the
disulphide species at 31.2 1.5 pmol cm
 2, albeit less than
the standard thiol sample.
Once again, the disparity in surface coverage does not
impact the conjugate stability since we have seen that
the disulphide systems are by far more stable than
both of the thiol conjugates and yet has lower surface
coverage. This surface-coverage-independent stability is
also observed with the polyT and polyA sequence
conjugates (refer to Table 2).
Comparing the results for stability of gold and silver
‘conjugates’ it can be seen that as anticipated, the
disulphide does not stabilize the silver nanoparticles to
the same extent as gold, due to weaker thiol–silver
interactions. Surface coverage eﬀects can again be
dismissed as the stabilizing factor when comparing
samples D2–Au (with a surface coverage of 59.9 6.7
pmol cm
 2) and T2–Ag (with a surface coverage of
64.4 3.0 pmol cm
 2) and yet there are vastly diﬀering
stabilities. Similarly, D1–Ag (surface coverage of
21.1 1.3 pmol cm
 2) is considerably less stable than
D3–Au (surface coverage of 12.6 0.8 pmol cm
 2) despite
their surface coverages being quite similar. It is worthy
to note, however, that the disulphide on silver remains
more stable than the ‘standard’ monothiol linker systems
on gold and this is in spite of similar surface coverages in
some cases e.g. D1–Ag (surface coverage of 21.1 1.3
pmol cm
 2) and TT3–Au (surface coverage 21.1 1.2
pmol cm
 2). This is highly signiﬁcant as it now allows
oligonucleotide–silver nanoparticle conjugates to be
exploited in a similar manner to gold nanoparticles.
Silver–oligonucleotide conjugate hybridization
As shown in Figure 4, hybridization between the
disulphide-immobilized oligonucleotide and a fully
complementary sequence induces a characteristically
sharp Tm melting proﬁle (monitored at 413nm). This is
a particularly exciting result since the hybridization was
not carried out in the normal ‘sandwich’ fashion. Instead
silver nanoparticles conjugated with a thioctic acid
modiﬁed sequence, 50- ATC CTG AAT GCG AAA
AAA AAA A MOD 30 (D4) were hybridized with the
‘unconjugated’ complement. This has been observed
previously with gold nanoparticles, but not silver
(27–29). This shows the eﬃcacy of the thioctic acid
terminated oligonucleotide–Ag conjugates and their
potential for employment in DNA detection.
Furthermore, investigations are underway to establish
oligonucleotide–Ag nanoparticle conjugates for DNA
detection purposes in a manner similar to that
of the established gold analogues. This is particularly
attractive as silver nanoparticles have a higher molar
extinction coeﬃcient than gold.
In conclusion, this data demonstrates the applicability
of thioctic acid to simple modiﬁcation of oligonucleo-
tides, producing enhanced performance with respect to
oligonucleotide–nanoparticle ‘conjugate’ stability. This
oﬀers a routine way forward for those requiring more
robust surface attachment chemistry for oligonucleotides
on gold or silver nanoparticles and in particular provides
surface chemistry for silver nanoparticles that allows their
use in a wide variety of conditions previously unthinkable.
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